Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
about
Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Comparison of the efficacy bet ...... single institution experience.
@en
Comparison of the efficacy bet ...... single institution experience.
@nl
type
label
Comparison of the efficacy bet ...... single institution experience.
@en
Comparison of the efficacy bet ...... single institution experience.
@nl
prefLabel
Comparison of the efficacy bet ...... single institution experience.
@en
Comparison of the efficacy bet ...... single institution experience.
@nl
P2093
P2860
P1476
Comparison of the efficacy bet ...... single institution experience.
@en
P2093
Hee Seung Kim
Hong Gyun Wu
Hyo Pyo Lee
Hyun Hoon Chung
Jae Weon Kim
Noh Hyun Park
Soon Beom Kang
Yong Sang Song
P2860
P304
P356
10.1111/J.1447-0756.2010.01223.X
P577
2010-06-01T00:00:00Z